GlobalData believes that mRNA vaccines may be more favourable to DNA vaccines because they do not have to overcome the nuclear membrane before transcription.
26 December 2018 Comment
19 December 2018 Analysis
Find out about the foundation for the first drugs using microbiome bacteria in the latest issue of Pharma Technology Focus
In this issue: A new class of cancer combo treatments, antidepressants in the environment, microbiome-based drug development, and more.
18 December 2018 News
Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to support drug development and life cycle management.
13 December 2018 News
The National Institute of Allergy and Infectious Diseases (NIAID), a National Institutes of Health (NIH) division, has announced plans to fund HIV care and prevention research in the southern US.
10 December 2018 News
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and Imperial College London have formed an alliance to develop new vaccines against known as well as unknown pathogens, which are...
3 December 2018 News
Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal.
29 November 2018 News
The European Commission has granted approval to Merck for its indications Delstrigo and Pifeltro to treat adults with HIV-1.
28 November 2018 News
India-based drugmaker Sun Pharmaceutical Industries has signed a definitive agreement to acquire Pola Pharma, a Japan-based pharma firm involved in the research, development, manufacture, and sale of branded and generic products.
27 November 2018 News
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for AstraZeneca’s Fasenra (benralizumab) to treat eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that can...